Trump push to combat drug trade may mean starting with
Trump push to combat drug trade may mean starting with China, not Mexico
If President-elect Donald Trump wants to fulfill his campaign promise of stemming the flow of drugs coming across the United States’ border with Mexico, he may want to start by looking at China.
Manufacturers and organized crime groups in the world’s most populous country are responsible for the majority of fentanyl -- the synthetic opioid that is 50 times more potent than heroin -- that ends up in the U.S. and the majority of precursor chemicals used by Mexican drug cartels to make methamphetamine, according to numerous published U.S. government reports.
“The Mexican cartels are buying large quantities of fentanyl from China,” Barbara Carreno, a spokesperson with the U.S. Drug Enforcement Administration (DEA), told FoxNews.com. “It’s much easier to produce than waiting around to grow poppies for heroin and it’s incredibly profitable.
The DEA estimates that a kilogram of fentanyl, which sells for between $2,500 and $5,000 in China, can be sold to wholesale drug dealers in the U.S. for as much as $1.5 million and that the demand for the drug due to the prescription opioid crisis in places like New England and the Midwest have kept the prices high.
Trump, along with numerous other presidential hopefuls, promised while on the stump in states hard-hit by drug addiction to quickly tackle the widespread use of drugs like fentanyl and heroin. While heroin addiction has been a concern for decades, in recent years the number of users of heroin and fentanyl -- and its more potent derivatives like carfentanil -- has skyrocketed as the government clamps down on the abuse of prescription opioids like OxyContin and Percocet.
"We're going to build that wall and we're going to stop that heroin from pouring in and we're going to stop the poison of the youth," Trump said during a September campaign stop in New Hampshire.
The problem with cracking down on fentanyl and its derivatives is that while these substances may be banned in the U.S., they may not be illegal in their country of origin. China, for example, only last year added 116 synthetic drugs to its controlled substances list, but failed to include carfentanil – a drug that is 10,000 times more potent than morphine and has been researched as a chemical weapon by the U.S., U.K., Russia, Israel, China, the Czech Republic and India.
“It can kill you if just a few grains gets absorbed through the skin,” Carreno said.
While Mexican cartels obtain these substances in large quantities through the murky backwaters of the Chinese black market, anybody with a credit card and Internet access can call one of the numerous companies in China’s freewheeling pharmaceutical industry that manufactures fentanyl and its more potent cousins.
Earlier this year, The Associated Press found at least 12 Chinese businesses that said they would export carfentanil to the United States, Canada, the United Kingdom, France, Germany, Belgium and Australia for as little as $2,750 a kilogram.
Besides synthetic opioids, Chinese companies are also producing massive amounts of the precursor chemicals used to make methamphetamine.
As the methamphetamine industry evolved over the last decade or so from small, homegrown operations in the U.S. to the super-labs run by Mexican cartels, cooks and producers of the drug have begun to rely more and more on China for their ingredients. Mexico now supplies 90 percent of the methamphetamine found in the U.S., and 80 percent of precursor chemicals used in Mexican meth come from China, according to a study by the U.S.-China Economic and Security Review Commission.
“China is the major source for precursor chemicals going to Mexico,” David Shirk, a global fellow at the Washington, D.C.-based Woodrow Wilson International Center for Scholars, told FoxNews.com. “The problem is finding who the connection is between organized crime groups in China and organized crime groups in Mexico.”
Shirk added that law enforcement and drug war experts generally have a good picture of the major players in Mexican organized crime, but the Chinese underworld is less well mapped and it is more difficult to pin down the major players in the drug trade there.
Despite U.S. efforts to crackdown on both the fentanyl and methamphetamine trades, U.S. government officials acknowledge that much of the onus lies with the Chinese. Chinese state officials take allegations of drug-related corruption seriously, launching investigations when deemed appropriate, but a U.S. State Department report found that drug-related corruption among local and lower-level government officials continues to be a concern.
When he takes office in January, Trump has a few things working in his favor in respect to combatting the drug trade.
One is the continued fracturing of some of Mexico’s largest and most powerful drug cartels. The Sinaloa Cartel, for example, was seen for years as an impenetrable drug organization until cracks began to appear in its armor following the re-arrest earlier this year of its leader, Joaquín “El Chapo” Guzmán, and the power struggle that ensued.
“When the violence goes up, business always goes down,” Shirk said.
Another factor that will help Trump’s war on drugs is U.S. anti-drug officials claim that their work in collusion with their Chinese counterparts is already helping greatly. Six months after China added a slew of synthetic drugs to its controlled substances list, monthly seizures in the U.S. of acetylfentanyl -- a weak variant of fentanyl -- were down 60 percent, the DEA reported.
“We’re continuing to work with the Chinese to see if they might control more of these substances,” Carreno said. “When they put controls on these substances it makes a huge difference.”
1
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...
Continue Reading
A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...
Continue Reading
Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...
Continue Reading
HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...
Continue Reading
Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...
Continue Reading
Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...
Continue Reading
OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...
Continue Reading
Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....
Continue Reading
What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...
Continue Reading
Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...
Continue Reading
Top 5 Most Recently Viewed Articles
NLS Pharmaceutics Ltd. Private Placement Overview NLS Pharmaceutics Ltd. (NASDAQ: NLSP, NASDAQ: NLSPW), a prominent Swiss biopharmaceutical firm, has disclosed an exciting new financing strategy. This initiative aims to raise up to $1 million through a private placement offering that encompasses the sale of approximately 322,580 common shares at a purchase price of $3.10...
Continue Reading
Insights into the Companion Animal Health Market Growth Verified Market Research, a recognized leader in market analysis, has published an exhaustive report on the Companion Animal Health Market. According to the findings, the market is expected to achieve a remarkable revenue of USD 43.14 billion by the end of the forecast period, growing at a compound annual growth rate...
Continue Reading
Tradable Achieves Significant Milestone in Tokenization Tradable is transforming the landscape of alternative investments by successfully tokenizing $1.7 billion worth of assets, marking a pivotal moment in its goal to democratize institutional-grade investment opportunities. With this milestone, Tradable not only positions itself as the third-largest platform for...
Continue Reading
So here’s the deal: Somnigroup International Inc. (NYSE: SGI) just dropped its financial bombshell for Q4 2025, showing consolidated sales growth of a staggering 55%. But before you start piling in, let’s dissect these numbers because they could be masking some serious issues under the hood. Sales Spike or Sales Mirage? The total net sales jumped to $1,868.4 million...
Continue Reading
Viper Energy Schedules Fourth Quarter 2024 Earnings Call In a recent announcement, Viper Energy, Inc. (NASDAQ: VNOM), a valued subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG), revealed its plan to release its financial results for the fourth quarter of 2024 before the market opens on February 24, 2025. This eagerly anticipated report comes as the company continues...
Continue Reading